All news

Aspirin: cancer prevention benefits outweigh risks for 55-75 age group

Added: Thursday 8 March 2012

US research suggests that for people aged 55 to 75, the risks of taking aspirin outweigh the cancer prevention benefits. Aspirin is well-known for being associated with gastrointestinal bleeding, but recent research also links it to macular degeneration. The authors of a recent analysis concluded that healthy people do not experience any significant reduction in either cardiovascular or cancer deaths when they take aspirin. Research in the area of secondary prevention is ongoing.